2013
DOI: 10.3390/ijms141020386
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Study of a Hoxa2 Gain-of-Function in Chondrogenesis: A Model of Idiopathic Proportionate Short Stature

Abstract: In a previous study using transgenic mice ectopically expressing Hoxa2 during chondrogenesis, we associated the animal phenotype to human idiopathic proportionate short stature. Our analysis showed that this overall size reduction was correlated with a negative influence of Hoxa2 at the first step of endochondral ossification. However, the molecular pathways leading to such phenotype are still unknown. Using protein immunodetection and histological techniques comparing transgenic mice to controls, we show here… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 64 publications
0
4
0
Order By: Relevance
“…For example, BMPR1A that ranked second overall is essential for embryogenesis [ 57 ], including skeletogenesis, and postnatal bone homeostasis [ 58 ]. Expression of BMPR1A was shown to be downregulated in a mouse model for human idiopathic proportionate short stature [ 59 ]. It is also involved in the regulation of adipogenesis and variants of BMPR1A are associated with human obesity [ 60 ].…”
Section: Discussionmentioning
confidence: 99%
“…For example, BMPR1A that ranked second overall is essential for embryogenesis [ 57 ], including skeletogenesis, and postnatal bone homeostasis [ 58 ]. Expression of BMPR1A was shown to be downregulated in a mouse model for human idiopathic proportionate short stature [ 59 ]. It is also involved in the regulation of adipogenesis and variants of BMPR1A are associated with human obesity [ 60 ].…”
Section: Discussionmentioning
confidence: 99%
“…CD5 has been previously described as being overexpressed in the synovial fluid of patients with advanced OA but has not been described previously in subchondral bone. Finally, overexpression of hypermethylated HOXA2 in murine models results in chondrodysplasia and delayed cartilage maturation ; similarly, its expression can delay endochondral ossification .…”
Section: Discussionmentioning
confidence: 99%
“…At days 28 and 56, HOXA2 , HOXA3 , and HOXA4 were in the top up-regulated genes, with HOXA4 having the largest fold change. Interestingly, gain-of-function mutations or overexpression of HOXA2 , HOXA3 , and HOXA4 impair chondrogenesis, limit skeletal development, decrease endochondral ossification regulators, and delay mineralization in animal models ( Creuzet et al, 2002 ; Deprez et al, 2013 ; Kanzler et al, 1998 ; Li and Cao, 2006 ; Massip et al, 2007 ; Seifert et al, 2015 ). HOXA5 was also highly up-regulated at both days 28 and 56, and mutations in this gene showed disordered patterning of limb bud development ( Pineault and Wellik, 2014 ).…”
Section: Discussionmentioning
confidence: 99%